secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0001104659-23-080024
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax stockholders approve 6.17M share increase under Amended 2015 Stock Plan
-------------------------------------------------------------------------------

- Proposal 5 approved: Amended 2015 Stock Plan with 15.1M for, 3.8M against; adds 6,170,000 authorized shares.
- Proposal 4 failed: officer exculpation charter amendment received 16.7M for, 2.1M against, but not approved.
- Directors elected: John C. Jacobs (18.1M for), Gregg H. Alton (11.3M for), Richard J. Rodgers (13.1M for).
- Advisory say-on-pay approved (15.7M for); frequency set at one year (17.8M for one-year option).
- Ratification of Ernst & Young as auditor passed with 41.4M for, 2.0M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/0001104659-23-080024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/tm2321057d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-080024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer